These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30996847)

  • 21. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017.
    Plachouras D; Kärki T; Hansen S; Hopkins S; Lyytikäinen O; Moro ML; Reilly J; Zarb P; Zingg W; Kinross P; Weist K; Monnet DL; Suetens C;
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point prevalence and risk factors of hospital acquired infections in a cluster of university-affiliated hospitals in Shiraz, Iran.
    Askarian M; Yadollahi M; Assadian O
    J Infect Public Health; 2012 Apr; 5(2):169-76. PubMed ID: 22541264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of healthcare-associated infections and antimicrobial use in China: Results from the 2018 point prevalence survey in 189 hospitals in Guangdong Province.
    Zhang Y; Zhong ZF; Chen SX; Zhou DR; Li ZK; Meng Y; Zhou JF; Hou TY
    Int J Infect Dis; 2019 Dec; 89():179-184. PubMed ID: 31580939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Healthcare-associated infections and antimicrobial use at a major referral hospital in Papua New Guinea: a point prevalence survey.
    Curtis SJ; Barnabas R; Cairns KA; Cameron D; Coghlan B; Jones R; Joseph J; Kali A; Kep D; Klintworth G; Levy S; Mason M; Norrie M; Peel T; Tamolsaian G; Telenge J; Tumu N; Stewardson AJ; Ak G;
    Lancet Reg Health West Pac; 2024 Jul; 48():101120. PubMed ID: 38993540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five-year point prevalence survey of healthcare-associated infections and antimicrobial use in a Japanese university hospital.
    Morioka H; Iguchi M; Tetsuka N; Kinoshita F; Tomita Y; Kato D; Hirabayashi A; Matsumoto A; Oka K; Kato H; Inagaki T; Kato Y; Kitagawa K; Ichikawa K; Kouyama Y; Kawamura N; Toyodome Y; Adachi N; Ito Y; Yagi T
    Infect Prev Pract; 2021 Sep; 3(3):100151. PubMed ID: 34647007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of And Factors Associated with Healthcare-associated Infections in Slovenian Acute Care Hospitals: Results of the Third National Survey.
    Klavs I; Serdt M; Korošec A; Lejko Zupanc T; Pečavar B;
    Zdr Varst; 2019 Mar; 58(2):62-69. PubMed ID: 30984296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Point Prevalence Survey of Antimicrobial Prescribing in a Nigerian Hospital: Findings and Implications on Antimicrobial Resistance.
    Fowotade A; Fasuyi T; Aigbovo O; Versporten A; Adekanmbi O; Akinyemi O; Goossens H; Kehinde A; Oduyebo O
    West Afr J Med; 2020; 37(3):216-220. PubMed ID: 32476113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-centre point-prevalence survey of hospital-acquired infections in Ghana.
    Labi AK; Obeng-Nkrumah N; Owusu E; Bjerrum S; Bediako-Bowan A; Sunkwa-Mills G; Akufo C; Fenny AP; Opintan JA; Enweronu-Laryea C; Debrah S; Damale N; Bannerman C; Newman MJ
    J Hosp Infect; 2019 Jan; 101(1):60-68. PubMed ID: 29730140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of health care-associated infections and antimicrobial resistance of the responsible pathogens in Ukraine: Results of a multicenter study (2014-2016).
    Salmanov AG; Vdovychenko SY; Litus OI; Litus VI; Bisyuk YA; Bondarenko TM; Davtian LL; Olifirova TF; Leleka MV; Kovalchuk OI; Dzevulska IV; Moroz VV; Kaminsky RF; Zhegulovych ZE; Kerechanyn IV
    Am J Infect Control; 2019 Jun; 47(6):e15-e20. PubMed ID: 31000318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point prevalence survey is useful for introducing effective surveillance of healthcare-associated infections.
    Pitkäpaasi M; Lehtinen JM; Kanerva M
    Infect Prev Pract; 2021 Dec; 3(4):100182. PubMed ID: 34877524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece.
    Kritsotakis EI; Kontopidou F; Astrinaki E; Roumbelaki M; Ioannidou E; Gikas A
    Infect Drug Resist; 2017; 10():317-328. PubMed ID: 29066921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic utilisation in adult and children patients in Kosovo hospitals.
    Krasniqi S; Versporten A; Jakupi A; Raka D; Daci A; Krasniqi V; Deva Z; Rashiti A; Brajshori N; Hajdari S; Bytyqi J; Neziri B; Goossens H; Raka L
    Eur J Hosp Pharm; 2019 May; 26(3):146-151. PubMed ID: 31428322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point prevalence of healthcare-associated infections and antibiotic use in a tertiary care teaching hospital in Nepal: A cross-sectional study.
    Shrestha SK; Shrestha S; Ingnam S
    J Infect Prev; 2022 Jan; 23(1):29-32. PubMed ID: 35126679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A multicenter point prevalence survey of healthcare-associated infections in Pakistan: Findings and implications.
    Saleem Z; Hassali MA; Godman B; Hashmi FK; Saleem F
    Am J Infect Control; 2019 Apr; 47(4):421-424. PubMed ID: 30471976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.
    Versporten A; Zarb P; Caniaux I; Gros MF; Drapier N; Miller M; Jarlier V; Nathwani D; Goossens H;
    Lancet Glob Health; 2018 Jun; 6(6):e619-e629. PubMed ID: 29681513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey.
    Abubakar U
    BMC Infect Dis; 2020 Jan; 20(1):86. PubMed ID: 32000722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of and risk factors for healthcare-associated infections in Slovenia: results of the second national survey.
    Klavs I; Kolman J; Lejko Zupanc T; Kotnik Kevorkijan B; Korošec A; Serdt M;
    Zdr Varst; 2016 Dec; 55(4):239-247. PubMed ID: 27703546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The first point prevalence survey of health care-associated infection and antimicrobial use in a Japanese university hospital: A pilot study.
    Morioka H; Hirabayashi A; Iguchi M; Tomita Y; Kato D; Sato N; Hyodo M; Kawamura N; Sadomoto T; Ichikawa K; Inagaki T; Kato Y; Kouyama Y; Ito Y; Yagi T
    Am J Infect Control; 2016 Jul; 44(7):e119-23. PubMed ID: 27372390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. THE GLOBAL POINT PREVALENCE SURVEY (PPS) OF ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE AMONG HOSPITALIZED CHILDREN IN GEORGIA.
    Korinteli IG; Mchedlishvili I; Javakhadze M; Versporten A; Goossens H; Phagava H; Pagava K
    Georgian Med News; 2019; (292-293):72-75. PubMed ID: 31560667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective surveillance of device-associated health care-associated infection in an intensive care unit of a tertiary care hospital in New Delhi, India.
    Kumar S; Sen P; Gaind R; Verma PK; Gupta P; Suri PR; Nagpal S; Rai AK
    Am J Infect Control; 2018 Feb; 46(2):202-206. PubMed ID: 29046215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.